03/04/2007 (Agence Europe) - The European Medicines Agency has just published draft guidelines for clinical trials. These guidelines will include a strengthening in security measures during initial phase 1 trials, particularly for: more innovative medicines that have an effect on the immune system; those on which there is little information or those where animal models do not allow for accurate predictions of the pharmacological or toxicological effects in humans. This paper will be...